Benefits of investment into modern medicines in Central-Eastern European countries.
about
Contribution of clinical trials to gross domestic product in Hungary.Implication of external price referencing and parallel trade on pharmaceutical expenditure: indirect evidence from lower-income European countries.Patient Access, Unmet Medical Need, Expected Benefits, and Concerns Related to the Utilisation of Biosimilars in Eastern European Countries: A Survey of Experts.
P2860
Benefits of investment into modern medicines in Central-Eastern European countries.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Benefits of investment into modern medicines in Central-Eastern European countries.
@en
type
label
Benefits of investment into modern medicines in Central-Eastern European countries.
@en
prefLabel
Benefits of investment into modern medicines in Central-Eastern European countries.
@en
P2093
P2860
P1476
Benefits of investment into modern medicines in Central-Eastern European countries
@en
P2093
András Inotai
Dinko Vitezic
Guenka Petrova
P2860
P356
10.1586/14737167.2014.868314
P50
P577
2013-12-19T00:00:00Z